Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

More News From Daily Xtreme

Kerevi back for Wallabies, 3 uncapped players also in squad

Oct 19, 2018

SYDNEY — Center Samu Kerevi has been recalled and three uncapped players have been included in Australia's 31-man squad for the third Bledisloe Cup test against New Zealand in Japan on Oct. 27. Wallabies coach Michael Cheika announced the squad on Thursday, giving Waratahs forward Jed Holloway, scrumhalf Jake Gordon and Melbourne Rebels blindside flanker Angus Cottrell a chance to push for test selection. Kerevi, who missed the Rugby Championship with a biceps injury, hasn't played since the third test against Ireland in June. Reece Hodge, who started in the centers for the Wallabies in all six tests in Kerevi's...

New Zealand All Blacks select 51 for season-ending tour

Oct 19, 2018

WELLINGTON, New Zealand — The All Blacks have taken the unprecedented step of selecting a player based in Japan among an enlarged squad of 51 for autumn test matches against Australia, Japan, England, Ireland and Italy. Flanker Matt Todd, who is playing for the Panasonic Wild Knights in Japan's top domestic competition, has been picked for the European section of New Zealand's tour in the absence of Sam Cane, who is convalescing after fracturing his neck. Todd is set to return to New Zealand next year in time to play for the Christchurch-based Crusaders in Super Rugby but would normally...

Australian Grand Prix to lead off F1 2019 schedule

Oct 19, 2018

MELBOURNE, Australia — The Australian Grand Prix has taken its usual place at the top of the calendar for the 2019 Formula One season, with Melbourne to host the opening race on March 17 at Albert Park. World governing body FIA said following a meeting of its World Motor Sport Council on Friday that 21 races will be held next year, with 11 in Europe, five in Asia, four in the Americas and one in Australia. ___ Dates, races and venues for 2019: March 17: Australia, Melbourne March 31: Bahrain, Sakhir April 14: China, Shanghai April 28: Azerbaijan, Baku May...

East to west, Rugby Australia switches venue for Bledisloe

Oct 19, 2018

PERTH, Australia — Rugby Australia is moving one of the Bledisloe Cup tests west to Perth next year, hoping that a change from the traditional venues will bring about a change in the Wallabies' fortunes against a dominant New Zealand in the annual series. The All Blacks have held the Bledisloe Cup since 2003 and clinched this year's series with wins in the first two matches in Sydney and Auckland. A third match is to be played on neutral ground in Yokohama, Japan, on Oct. 27. Rugby Australia on Thursday said the Western Australia match would be held on Aug....

All Blacks experiment against Argentina ahead of World Cup

Oct 19, 2018

WELLINGTON, New Zealand — All Blacks coach Steve Hansen says Saturday's Rugby Championship test against Argentina in Buenos Aires is part of a two-match experiment, imperative to New Zealand's defense of the World Cup in Japan next year. Hansen said the All Blacks' last two matches against Argentina and South Africa will allow coaches and players to simulate conditions New Zealand might encounter in the knockout stages of a World Cup. He said if New Zealand reaches the playoff stages of the world tournament it will have to win two "big" matches to reach the final. Its next two tests...

NHL Livescore